Details of the Drug

General Information of Drug (ID: DMSTTV9)

Drug Name
Pemoline
Indication
Disease Entry ICD 11 Status REF
Attention deficit hyperactivity disorder 6A05.Z Approved [1]
Affected Organisms
Humans and other mammals
ATC Code
N06BA05: Pemoline
N06BA: Centrally acting sympathomimetics
N06B: PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS
N06: PSYCHOANALEPTICS
N: NERVOUS SYSTEM
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
Chemical Identifiers
Formula
C9H8N2O2
Canonical SMILES
C1=CC=C(C=C1)C2C(=O)N=C(O2)N
InChI
InChI=1S/C9H8N2O2/c10-9-11-8(12)7(13-9)6-4-2-1-3-5-6/h1-5,7H,(H2,10,11,12)
InChIKey
NRNCYVBFPDDJNE-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
4723
ChEBI ID
CHEMBL7953
CAS Number
2152-34-3
UNII
7GAQ2332NK
DrugBank ID
DB01230
TTD ID
D0D5GG
Drug-Molecule Activity Atlas (DMA)NEW Click to Jump to the Detailed DMA Information of This Drug
Drug Pharmacogenomic Perturbation (DPP)NEW Click to Jump to the Detailed DPP Information of This Drug
Drug ADMET Endpoint Profile (DAE)NEW Click to Jump to the Detailed DAE Information of This Drug
Combinatorial Drugs (CBD) Click to Jump to the Detailed CBD Information of This Drug

References

1 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015